- 专利标题: Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
-
申请号: US17463007申请日: 2021-08-31
-
公开(公告)号: US12059479B2公开(公告)日: 2024-08-13
- 发明人: Judith Meis , Anthony Person , Cynthia Chin , Jerome Jendrisak , Gary Dahl
- 申请人: CELLSCRIPT, LLC
- 申请人地址: US WI Madison
- 专利权人: CELLSCRIPT, LLC
- 当前专利权人: CELLSCRIPT, LLC
- 当前专利权人地址: US WI Madison
- 代理机构: Casimir Jones, S.C.
- 代理商 Jason R. Bond
- 主分类号: A61K48/00
- IPC分类号: A61K48/00 ; A61K31/7105 ; A61K33/06 ; A61K38/00 ; C12N5/074 ; C12N5/077 ; C12N5/0793 ; C12N15/10 ; C12N15/87 ; C12P19/34 ; C12P19/38 ; C12P21/02
摘要:
The present invention relates to compositions, kits and methods for making and using RNA compositions comprising in vitro-synthesized ssRNA inducing a biological or biochemical effect in a mammalian cell or organism into which the RNA composition is repeatedly or continuously introduced. In certain embodiments, the invention provides compositions and methods for changing the state of differentiation or phenotype of a human or other vertebrate cell. For example, the present invention provides mRNA and methods for reprogramming cells that exhibit a first differentiated state or phenotype to cells that exhibit a second differentiated state or phenotype, such as to reprogram human somatic cells to pluripotent stem cells.
公开/授权文献
信息查询